FDA recall D-1168-2017

Pfizer Inc. · Class II · drug

Product

Levophed (norepinephrine bitartrate) injection, USP, 4 mg/4 mL (1mg/mL), 4mL Fill in 5 mL Single dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3375-04

Reason for recall

Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.

Distribution

United States Nationwide (including Puerto Rico) and Singapore

Key facts

Status
Terminated
Initiation date
2017-08-22
Report date
2017-09-27
Termination date
2023-02-19
Voluntary/Mandated
Voluntary: Firm initiated
Location
New York, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1168-2017